Search is Powered by Google
MRSA / Drug Resistance News

Two Hour MRSA And Staph Blood Test Gets FDA 510 (k) Clearance

rate icon Editor's Choice
Main Category: MRSA / Drug Resistance
Also Included In: Infectious Diseases / Bacteria / Viruses;  Blood / Hematology;  Regulatory Affairs / Drug Approvals
Article Date: 02 Jan 2008 - 13:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:5 stars

4.75 (4 votes)

Health Professional:5 stars

4.7 (10 votes)

Article Opinions: 0 posts

The FDA (Food and Drug Administration) have given clearance for the BD GeneOhm StaphSR assay. It is the first assay available to identify both Staphylococcus aureus (SA) and methicillin-resistant Staphylococcus aureus (MRSA) rapidly and at the same time from patients with positive blood cultures.

This will make it possible for doctors to use the right treatment at the right time for patients with bloodstream infections.

Thomas Davis, M.D., Ph.D., Director of Clinical Microbiology, Wishard Memorial Hospital, Indianapolis, Indiana, said "The BD GeneOhm StaphSR assay provides a rapid, definitive identification of SA and MRSA from blood cultures. This allows for more appropriate isolation procedures and agent-specific antimicrobial therapy, resulting in reduced patient morbidity and mortality as well as an overall reduction in healthcare costs,"

Vince Forlenza, Executive Vice President, BD, said "The launch of the BD GeneOhm StaphSR assay in the United States further demonstrates BD's commitment to helping healthcare providers rapidly identify, prevent and control HAIs. It also illustrates our desire to provide customers with a complete menu of assays and tools to combat these potentially deadly infections."

The BD GeneOhm StaphSR assay gives a result within two hours directly from a positive blood culture. The makers say the assay is easy to perform and takes up less technologist time when compared to traditional microbiology algorithms, which can take up to two days to come back with results.

Studies have indicated that if doctors have crucial microbiology data earlier on it is possible to reduce mortality, length of hospital stay, as well as variable costs.

Currently, the BD GeneOhm™ MRSA assay quickly detects people who are colonized with MRSA and gives infection control professionals a better opportunity to break the chain of MRSA transmission.

http://www.bd.com.

Written by - Christian Nordqvist
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
Anti-Bacterial Personal Hygiene Products Triclosan And Triclocarban May Not Be Worth Potential Risks
12 Jul 2008
A new study by UC Davis researchers calls into question the widespread use of two active ingredients -- triclocarban and triclosan -- in personal hygiene products, including anti-bacterial bar and liquid soaps...


When Your Cycle Becomes a Major Headache
When Your Cycle Becomes a Major Headache

Cathy's gets as many as 12 to 15 headaches a month and they are all associated with her menstrual cycle. Migraines like hers tend to last longer and be more severe than other migraines. Figuring out what was triggering her headaches helped Cathy and her doctor come up with a successful treatment plan.

more videos are available in our health videos section.